Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. https://www.biorxiv.org/content/10.1101/2023.03.07.531620v1?med=mas
Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. https://www.biorxiv.org/content/10.1101/2023.03.07.531620v1?med=mas